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Abstract
Objective:  To  describe  the  proﬁle  of  patients  with  genitourinary  abnormalities  treated  at  a
tertiary hospital  genetics  service.
Methods:  Cross-sectional  study  of  1068  medical  records  of  patients  treated  between  April/2008
and August/2014.  A  total  of  115  cases  suggestive  of  genitourinary  anomalies  were  selected,
regardless  of  age.  A  standardized  clinical  protocol  was  used,  as  well  as  karyotype,  hormone
levels and  genitourinary  ultrasound  for  basic  evaluation.  Laparoscopy,  gonadal  biopsy  and
molecular studies  were  performed  in  speciﬁc  cases.  Patients  with  genitourinary  malformations
were classiﬁed  as  genitourinary  anomalies  (GUA),  whereas  the  others,  as  Disorders  of  Sex  Dif-
ferentiation  (DSD).  Chi-square,  Fisher  and  Kruskal--Wallis  tests  were  used  for  statistical  analysis
and comparison  between  groups.
Results:  80  subjects  met  the  inclusion  criteria,  91%  with  DSD  and  9%  with  isolated/syndromic
GUA. The  age  was  younger  in  the  GUA  group  (p<0.02),  but  these  groups  did  not  differ  regarding
external and  internal  genitalia,  as  well  as  karyotype.  Karyotype  46,XY  was  veriﬁed  in  55%  and
chromosomal  aberrations  in  17.5%  of  cases.  Ambiguous  genitalia  occurred  in  45%,  predominantly
in 46,XX  patients  (p<0.006).  Disorders  of  Gonadal  Differentiation  accounted  for  25%  and  con-
genital adrenal  hyperplasia,  for  17.5%  of  the  sample.  Consanguinity  occurred  in  16%,  recurrence
ate  in  20%  and  interrupted  follow-up  in  31%  of  cases.in 12%,  lack  of  birth  certiﬁc∗ Corresponding author.
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Conclusions:  Patients  with  DSD  predominated.  Ambiguous  genitalia  and  abnormal  sexual  differ-
entiation were  more  frequent  among  infants  and  prepubertal  individuals.  Congenital  adrenal
hyperplasia  was  the  most  prevalent  nosology.  Younger  patients  were  more  common  in  the
GUA group.  Abandonment  and  lower  frequency  of  birth  certiﬁcate  occurred  in  patients  with
ambiguous or  malformed  genitalia.  These  characteristics  corroborate  the  literature  and  show
the biopsychosocial  impact  of  genitourinary  anomalies.
© 2015  Sociedade  de  Pediatria  de  São  Paulo.  Published  by  Elsevier  Editora  Ltda.  This  is  an  open
access article  under  the  CC  BY  license  (https://creativecommons.org/licenses/by/4.0/).
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Perﬁl  de  pacientes  com  anormalidades  geniturinárias  atendidos  em  servic¸o
de  genética  clínica  no  sistema  único  de  saúde
Resumo
Objetivo:  Descrever  o  perﬁl  de  pacientes  com  anormalidades  geniturinárias  atendidos  em
servic¸o de  genética  de  hospital  terciário.
Métodos:  Estudo  transversal  de  1.068  prontuários  de  pacientes  atendidos  entre  abril/2008
e agosto/2014.  Foram  selecionados  115  casos  sugestivos  de  anomalias  geniturinárias,  inde-
pendentemente  da  idade.  Usaram-se  protocolo  clínico  padronizado,  cariótipo,  hormônios  e
ultrassonograﬁa  geniturinária  para  avaliac¸ão  básica.  Laparoscopia,  biopsia  gonadal  e  estudos
moleculares  foram  feitos  em  casos  especíﬁcos.  Pacientes  com  malformac¸ões  geniturinárias
foram classiﬁcados  como  defeitos  geniturinários  (DGU),  os  demais,  como  distúrbios  da
diferenciac¸ão do  sexo  (DDS).  Usaram-se  qui-quadrado,  Fisher  e  Kruskal-Wallis  para  análise
estatística e  comparac¸ão  entre  os  grupos.
Resultados:  Preencheram  os  critérios  de  inclusão  80  sujeitos,  91%  com  DDS  e  9%  com  DGU
isolados/sindrômicos.  A  idade  foi  menor  no  grupo  DGU  (p<0,02),  mas  esses  grupos  não  diferi-
ram quanto  a  genitália  externa,  interna  e  cariótipo.  Veriﬁcou-se  cariótipo  46,XY  em  55%  e
aberrac¸ões cromossômicas  em  17,5%  dos  casos.  Ambiguidade  genital  ocorreu  em  45%,  predomi-
nou em  pacientes  46,XX  (p<0,006).  Distúrbios  da  diferenciac¸ão  gonadal  representaram  25%  e
hiperplasia  adrenal  congênita;  17,5%  da  amostra.  Consanguinidade  ocorreu  em  16%,  recorrência
em 12%,  ausência  de  registro  civil  em  20%  e  interrupc¸ão  do  seguimento  em  31%  dos  casos.
Conclusões:  Predominaram  pacientes  com  DDS.  Ambiguidade  genital  e  diferenciac¸ão  sexual
anômala  foram  mais  frequentes  entre  recém-nascidos  e  pré-púberes.  Hiperplasia  adrenal  con-
gênita foi  a  nosologia  mais  prevalente.  Pacientes  mais  jovens  pertenciam  ao  grupo  DGU.  Menor
frequência  de  registro  civil  e  abandono  ocorreram  em  pacientes  com  genitália  ambígua  ou  mal-
formada. Essas  características  corroboram  a  literatura  e  evidenciam  o  impacto  biopsicossocial
das anormalidades  geniturinárias.
©  2015  Sociedade  de  Pediatria  de  São  Paulo.  Publicado  por  Elsevier  Editora  Ltda.  Este  é  um  artigo
Open Access  sob  a  licença  CC  BY  (https://creativecommons.org/licenses/by/4.0/deed.pt).
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enitourinary  abnormalities  (GUA)  represent  35--45%  of
irth  defects  and  include  a  wide  range  of  structural  abnor-
alities  of  the  urinary  and  reproductive  tracts,  whose
ollective  occurrence  reﬂects  their  embryological  origin  and
ommon  genetic  control.1--3 The  clinical  spectrum  extends
rom  minor  anomalies  such  as  glandular  hypospadias  to
evere  conditions  such  as  bladder  exstrophy.  The  clini-
al  presentation  may  be  isolated  or  associated  with  other
natomical  defects  and  present  syndromic  conditions.  The
tiology  comprises  genetic  causes  resulting  from  chro-
osomal,  monogenic  or  multifactorial  abnormalities,  not
enetic,  associated  with  exposure  to  teratogens,  and  there
lso  the  unknown  causes.1,4
Disorders  of  Sex  Differentiation  (DSD)  are  a  special  group
f  GUA  in  which  the  development  of  genetic,  gonadal  or
t
s
inatomical  sex  is  atypical  or  incongruous.  Clinical  manifes-
ations  range  from  classical  genital  ambiguity,  manifested
t  birth,  to  infertility  in  adults.4,6--11 Clinical  heterogeneity
nd  the  use  of  different  inclusion  criteria,  collecting  meth-
ds,  coding  and  recording  of  GUA  account  for  wide  variations
n  prevalence.  With  the  exception  of  minor  abnormalities,
uch  as  isolated  hypospadias  with  a  prevalence  of  1:250  live
irths,  some  disorders  may  be  as  rare  as  1:100,000,  as  in
loacal  exstrophy.12,13 In  the  SDD  group,  a  global  prevalence
f  1--2:10,000  births  is  assumed,2,4,9,11 which  put  these  con-
itions  in  the  group  of  so-called  rare  diseases,  recent  focus
f  health  care  policies  in  genetics  in  the  National  Health
ystem  (Sistema  Único  de  Saúde  --  SUS).14The  management  of  patients  with  GUA  requires  a  mul-
idisciplinary  approach  in  view  of  the  underlying  complex
urgical,  endocrine,  genetic,  social,  psychological,  and  eth-
cal  issues.4,6--10 All  these  aspects  make  GUA  an  important
 clin
D
t
t
g
A
p
c
(
(
g
o
a
a
t
w
a
i
a
c
m
t
f
a
u
y
o
(
a
w
a
s
K
l
c
O
R
A
a
o
a
(
G
t
t
o
a
f
b
m
a
dProﬁle  of  patients  with  genitourinary  anomalies  treated  in  a
epidemiological  and  clinical  challenge.  So,  with  the  prospect
of  subsidizing  health  care  improvement  proposals  in  this
area,  the  objective  of  this  study  was  to  describe  the  clin-
ical  proﬁle  of  patients  with  GUA  treated  in  clinical  genetics
service  at  a  tertiary  hospital  in  the  SUS.
Method
Descriptive  and  cross-sectional  study  based  on  analysis
of  1068  digital  medical  records  of  patients  seen  in  the
Servic¸o  de  Genética  Clínica  of  the  Hospital  Universitário
Professor  Alberto  Antunes  of  the  Universidade  Federal  de
Alagoas  (SGC/HUPAA/UFAL)  between  April  2008  and  August
2014.  This  service,  unique  in  the  state,  serves  the  entire
SUS  demand.  The  cases  are  referred  via  Coordenac¸ão  de
Regulac¸ão  da  Assistência,  with  an  average  volume  of  eight
new  cases  per  week.  Patients  under  the  age  of  18  who  have
morphogenesis  defects  with  or  without  association  with  psy-
chomotor  retardation/intellectual  disabilities  comprise  the
predominant  group.
A  total  of  115  eligible  cases  were  mapped  from  the  search
of  the  following  descriptors,  regardless  of  age  at  ﬁrst  medi-
cal  consultation:  genital  ambiguity;  micropenis;  hypospadias
(any  grade);  posterior  labial  fusion;  gynecomastia;  crypt-
orchidism;  clitoromegaly;  primary  amenorrhea;  secondary
sexual  underdevelopment;  gonadal  dysgenesis.  Cases  with
incomplete  description  of  the  external  genital  morphology,
karyotype  absence,  and  conclusive  diagnosis  of  conditions
outside  the  GUA  spectrum,  such  as  inguinal  hernias  and  Noo-
nan  syndrome,  were  excluded.  The  ﬁnal  sample  consisted  of
80  subjects.
Data  were  obtained  using  the  own  protocol  of  the  GUA
clinic  consisting  of  history  of  present  complaint  and  gesta-
tional  history,  genetic  and  environmental  risk  factors,  and
general  physical  examination  with  emphasis  on  genital  mani-
festations.  This  protocol  was  established  in  2009  and  applied
prospectively  to  70  (87%)  cases.  Data  from  the  remaining  10
(13%)  patients  treated  in  2008  were  obtained  from  the  digital
medical  record  of  the  service.
Micropenis  was  deﬁned  as  penile  length  less  than  2.5
standard  deviations  for  age;  cryptorchidism,  as  extra-scrotal
position  of  the  testis;  and  genital  ambiguity  were  classiﬁed
according  to  Prader’s  criteria5:  P1  --  Genitalia  indistinguish-
able  from  female,  except  for  enlarged  phallus;  P2  --  Phallus
further  enlarged,  labioscrotal  fusion  and  without  urogeni-
tal  sinus;  P3  --  Phallus  of  penile  appearance,  almost  total
labioscrotal  fusion  and  perineal  opening  of  the  urogenital
sinus;  P4  --  Enlarged  phallus,  complete  labioscrotal  fusion
and  penoscrotal  urogenital  sinus  opening;  P5  --  Phallus  of
penile  appearance,  complete  labioscrotal  fusion,  urogenital
sinus  opening  in  the  body  of  the  phallus  or  balanic  area.15
The  basic  complementary  evaluation  included  peripheral
blood  karyotype  with  GTG  banding  and  band  resolutions  of
400--450.  At  least  40  metaphases  per  patient  were  analyzed
in  the  Human  Cytogenetics  Laboratory  at  the  Universidade
Estadual  de  Ciências  da  Saúde  de  Alagoas  (UNCISAL),  in
addition  to  directed  hormonal  tests,  ultrasound  of  the  gen-
itourinary  tract  (GUT)  and,  if  necessary,  laparoscopy  and
gonadal  biopsy.
Investigation  of  the  following  genes  was  done  in  part-
nership  with  the  Grupo  Interdisciplinar  de  Estudos  da
h
i
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eterminac¸ão  e  Diferenciac¸ão do  Sexo  (GIEDDS)  and  Cen-
ro  de  Biologia  Molecular  e  Engenharia  Genética  (CBMEG)  of
he  Universidade  Estadual  de  Campinas  (UNICAMP):  andro-
en  receptor  (AR),  nuclear  receptor  subfamily  5,  group
,  member  1  (NR5A1);  steroid-5-alpha-reductase,  alpha
olypeptide  2  (SRD5A2);  sex  determining  region  Y  (SRY);
ytochrome  P450,  family  21,  subfamily  A,  polypeptide  2
CYP21A2),  and  hydroxysteroid  (17-beta)  dehydrogenase  3
HSD17B3).
Cases  of  genitourinary  malformations  were  classiﬁed  as
enitourinary  defects  (GUD)  and  the  others  as  Disorders
f  Sex  Differentiation  (DSD).  The  independent  variables
nd  their  categories  of  analysis  include  the  demographic
nd  clinical  characteristics  and  the  genetic  characteris-
ics.  The  collected  demographic  and  clinical  characteristics
ere:  external  genital  morphology  (ambiguous,  feminine
ppearance,  male  appearance,  or  malformed),  GUT  ﬁnd-
ngs  (Müllerian  derivatives,  Wolfﬁan  derivatives,  renal
nomalies),  age  (<1;  1--9;  10--19;  >19  years),  how  the
hild  is  raised  (family  deﬁnition  of  social  gender  role  as
ale,  female,  or  not  deﬁned,  regardless  of  civil  regis-
ration),  civil  registration  (male,  female,  unregistered),
ollow-up  interruption/interruption  reasons  (change  of
ddress,  death,  withdrawal).  Genetic  characteristics  eval-
ated  were:  inbreeding,  recurrence  and  maternal  age  ≥35
ears  (yes  or  no),  karyotype  (46,XY;  46,XX;  other),  presence
f  pathogenic  mutation/polymorphism  in  the  studied  genes
yes  or  no).
Data  were  tabulated  and  analyzed  using  Microsoft  Excel
nd  Epi-InfoTM version  3.5.2  softwares.  Descriptive  analysis
ith  frequency  distribution,  measures  of  central  tendency,
nd  dispersion  was  performed.  Fisher’s  exact  test  and  chi-
quare  were  used  for  analysis  of  categorical  variables  and
ruskal--Wallis  test  for  equality  of  means.  A  signiﬁcance
evel  of  5%  (p<0.05)  was  considered.  This  study  had  ethi-
al  approval  on  09/10/2013  (CAAE  17197113.8.0000.5013;
pinion  390.134).
esults
mong  80  GUA  subjects  in  the  sample,  73  (91%)  were  deﬁned
s  having  DSD  diagnosed  and  the  other  as  having  GUD  alone
r  syndromic.  Table  1  shows  the  distribution  of  general  char-
cteristics  of  subjects  according  to  these  groups.
The  age  at  presentation  ranged  from  zero  to  38,  with  55
69%)  under  six  years.  The  average  age  was  four  months  in
UD  group  and  6.8  years  in  DSD  group  (p<0.02).  In  the  lat-
er,  there  was  a  mean  age  distribution  gradient  in  relation
o  the  genital  morphology,  of  2.9±6.4  years  in  the  ambigu-
us  genitalia  group,  6.5±10.2  years  in  the  genitalia  of  male
ppearance  group,  and  5.5±9.1  years  in  the  genitalia  of
emale  appearance  group  (p<0.01).
Ambiguous  genitalia  occurred  in  36  (45%)  cases,  followed
y  genitalia  of  male  appearance,  female  appearance,  and
alformed,  without  preferential  distribution  between  DSD
nd  GUD  groups.  GUT  was  evaluated  in  75  patients.  Wolfﬁan
erivatives  were  present  in  38  (51%)  subjects,  six  of  whom
ad  associated  renal  anomalies.
A  46,XY  karyotype  was  found  in  44  (55%)  patients;  46,XX
n  22  (27.5%);  and  chromosomal  abnormalities  in  14  (17.5%).
here  were  no  statistically  signiﬁcant  differences  between
94  Gazzaneo  IFP  et  al.
Table  1  Distribution  of  demographic,  clinical,  and  cytogenetic  characteristics  of  subjects  in  relation  to  disorder  group.
Characteristics  Genitourinary  defects  Disorders  of  sexual  differentiation  p-value
Age  in  years,  n  (%)  0.02a
0  6  (85.5)  32  (43.8)
1--9 1  (14.5)  16  (22)
10--19 --  18  (24.6)
>19 --  7  (9.6)
Mean±SD 0.14  (±0.37)  6.8  (±9.58)
External  genital  morphology,  n  (%)  0.50b
Ambiguous  --  36  (49.3)
Male 3  (43) 20  (27.3)
Female -- 17  (23.4)
Malformed  4  (57) --
Findings  of  the  internal  genitourinary  tract,  n  (%)  0.51b
Müller’s  derivatives  2  (28.5)  35  (48)
Wolf’s derivatives 3  (43)  35  (48)
Renal anomalies 2  (28.5)  4  (5.4)
Karyotype, n  (%) 0.64b
46,XY  4  (57) 40  (54.7)
46,XX 2  (28.5) 20  (27.3)
Other 1  (14.5) 13  (18)
Absence of  civil  registration,  n  (%) 3  (43) 13  (17.8) 0.13b
Reasons  for  withdrawal,  n  (%) 0.56
Death 2  (50) 3  (66.7)
Change of  address -- 4  (19)
Withdrawal 2  (50) 14  (14.3)
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b Fisher’s exact test.
SD  and  GUD  groups  for  the  presence  of  cytogenetic  abnor-
alities.
Table  2  shows  the  distribution  of  external  and  inter-
al  genital  manifestations  in  relation  to  karyotype.  Genital
mbiguity  was  more  frequent  in  the  46,XX  group  (p<0.006).
ix  patients  with  Müllerian  derivatives  had  Y  chromosome
emonstrable  by  cytogenetics  or  molecular  technique.
Table  3  shows  the  clinical  categories.  All  found  chro-
osomal  abnormalities  had  pathogenic  relationship  with
heir  phenotypes.  Regarding  the  investigated  genes,  muta-
ions/polymorphisms  were  found  in  15  (18.8%)  cases  to  date.
Twenty-two  (27.5%)  patients  remain  under  diagnostic
nvestigation,  only  one  of  them  with  46,XX  karyotype.
mong  the  rest,  14  have  hormonal  proﬁle  suggestive  of
efect  in  androgen  synthesis  or  action  and  seven  remain  as
diopathic  or  unclear.  No  pathogenic  mutation  was  found  so
ar  in  the  genes  investigated  in  these  subjects.
As  a  group,  the  disorders  of  gonadal  differentiation  were
he  most  common,  accounted  for  20  (25%)  cases.  Among
hese,  it  was  found  the  largest  number  of  cytogenetic
bnormalities  and  one  of  the  lowest  frequency  of  genital
mbiguity.
Congenital  adrenal  hyperplasia  was  the  most  frequent
osological  diagnosis  in  the  sample  (17.5%).  In  this,  as  in
he  group  of  defects  in  androgen  synthesis  or  action,  the
ighest  frequency  of  genital  ambiguity  was  found.Consanguinity  was  found  in  11  (16%)  families,  nine  (12%)
ith  recurrence  of  the  disorder,  all  from  the  DSD  group.
aternal  age  ≥35  years  occurred  in  eight  (10%)  cases,  only
ne  of  these  in  GUD  group.
p
l
sSixteen  (20%)  children  had  no  civil  registration  and  only
ne  had  the  social  gender  role  not  deﬁned,  without  sta-
istical  differences  between  DSD  and  GUD  groups  (p<0.13)
Table  1).  However,  the  lack  of  civil  registration  was  higher
n  cases  of  ambiguity  or  external  genital  malformation
p<0.02).
There  was  interruption  of  outpatient  follow-up  in  25
31%)  cases,  mainly  by  withdrawal.  This  result  did  not  differ
etween  GUD  and  DSD  groups  (Table  1),  as  well  as  between
hose  living  in  the  city  or  in  the  country  (p<0.20).  On  the
ther  hand,  it  was  signiﬁcantly  lower  in  patients  with  genital
mbiguity  or  malformed  genitalia  (p<0.01).
iscussion
he  SGC/HUPAA/UFAL  is  a  referral  service  for  people  with
irth  defects  in  the  state  since  2003.  A  survey  performed  in
007  of  the  actions  involved  in  the  care  of  patients  with  gen-
tal  ambiguity  in  this  hospital  revealed  some  obstacles  such
s  lack  of  information,  difﬁcult  access  to  tests,  discontinua-
ion  of  follow-up,  and  disconnection  between  the  services.16
he  intention  of  changing  this  reality  determined  in  2008
he  beginning  of  an  integrated  outpatient  clinic  of  genetics
nd  psychoanalysis  in  the  SGC/HUPAA/UFAL.17 The  results
iscussed  here  comes  from  the  systematic  care  of  patients
rovided  at  this  clinic.
In this  sample,  there  was  predominance  of  DSD  over  iso-
ated  and  syndromic  GUD.  Although  subtle  isolated  GUD,
uch  as  glandular  hypospadias,  are  very  common  in  the
Proﬁle  of  patients  with  genitourinary  anomalies  treated  in  a  clinical  genetics  service  95
Table  2  Distribution  of  subjects  according  to  external  and  internal  genitals  characteristics  in  relation  to  karyotype.
Characteristics  46,XY
n  (%)
46,XX
n  (%)
Other  n  (%)  p-value
Chi-square
External  genital  morphology
Ambiguous  19  (43.2)  15  (68.1)  2  (14.2)
Prader 1  1  (2.3)  1  (4.5)  --
Prader 2  1  (2.3)  2  (9.1)  1  (7.1)
Prader 3  5  (11.3)  11  (50)  1  (7.1)
Prader 4  12  (27.3)  --  --
Prader 5  --  1  (4.5)  --
Male (micropenis,  hypospadias  and/or  cryptorchidism)  22  (50)  --  1  (7.1)
Female (normal,  child  or  hypoplastic) 2  (4.5) 5  (22.8) 10  (71.6)
Malformed  1  (2.3) 2  (9.1) 1  (7.1)
Total 44  (55)  22  (27.5)  14  (17.5)  0.006
Findings of  internal  genitourinary  tract  <0.001
Müller’s derivatives  3  (7.5)  22  (100)  12  (92.3)
Wolf’s derivatives  37  (92.5)  --  1  (7.7)
Table  3  Distribution  of  clinical  categories  according  to  external  genital  morphology,  how  the  child  is  raised,  and  diagnostic
methods used.
Clinical  categories  (n)  External
genitalia
How  the  child
is raised
Diagnostic  methods  B.  gonadal  (n)
Classical  cytogenetics  Gene  seq.
Turner  syndrome  (9)  FA  F  45,X,  45,X/46,X,r(X)  --  --
DGP XX  e  XY  (4)  FA  F  46,XX,  46,XY  NR5A1,  SRY  --
Other gonadal  dysgenesis  (6)  P2--P4,  MA  F,  M,  ND  46,XY,  45,X,a
45,X/46,XY,
45,X/47,XY+21
NR5A1,  SRY  (3)
Ovarian-testicular  SDD  (1)  P3  F  46,XX  --  (1)
5-reductase  deﬁciency  II  (2)  FA,  P4  F,  M  46,XY  AR,  SRD5A2  (1)
HSD17B3 deﬁciency  (1)  P3  F  46,XY  AR,  SRD5A2,
HSD17B3
(1)
Under investigation  (14)  MA,  P2--P4  M,  F  46,XY  AR,  NR5A1,
SRD5A2
(2)
Congenital  adrenal  hyperplasia  (14)  P1--P5,  MA  F,  M  46,XX,  46,XY  CYP21A2  --
Hypogonadotropic  hypogonadism  (12)  MA,  FA  M,  F  46,XX,  46,XY  --
Idiopathic or  unenlightened  (8)  P1--P4,  MA  M,  F  46,XY,  46,XX  AR,  NR5A1,
SRD5A2,
HSD17B3
--
Genitourinary  defects  (7)  MA,  MF  M,  F  46,XX,  46,XY,
47,XX+18
--
Other: 2  MA,  FA  M,  F  46,XY,  46,XY,
der(22)t(X;22)
(p11.4;p13)mat
SRY  (2)
P1, ambiguous genitalia Prader grade I; P2, ambiguous genitalia Prader grade II; P3, ambiguous genitalia Prader grade III; P4, ambiguous
genitalia Prader grade IV; P5, ambiguous genitalia Prader grade V; MA, genitalia of male appearance±micropenis, glandular hypospadias,
and cryptorchidism; FA, normal genitalia of female appearance, infantile or hypoplastic; MF: malformed genitalia; F, child raised as
female; M, child raised as male; ND, not deﬁned how the child is raised; AR, androgen receptor; NR5A1, nuclear receptor subfamily 5,
group A, member 1; SRD5A2, steroid-5-alpha-reductase, alpha polypeptide 2; SRY, sex determining region Y; CYP21A2, cytochrome P450,
family 21, subfamily A, polypeptide 2; HSD17B3, hydroxysteroid (17-beta) dehydrogenase 3.
a Y chromosome demonstrable by molecular technique.
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opulation,13 this  result  is  not  surprising,  as  the  common
ractice  is  not  referring  these  patients  for  etiological  inves-
igation.  On  the  other  hand,  the  small  number  of  cases  with
yndromic  GUD  may  reﬂect  the  rarity  and  severe  clinical
ourse  of  these  conditions  usually  associated  with  death.
owever,  once  recognized,  these  cases  are  usually  referred
or  evaluation  at  an  early  age,  as  seen  in  this  cohort.
DSD  group  was  heterogeneous  regarding  the  age  of  refer-
al  and  clinical  manifestations.  The  observed  distribution
radient  revealed  that  in  infants  and  prepubescent  there
s  a  predominance  of  cases  of  genital  ambiguity  or  signs
uggestive  of  abnormal  sexual  differentiation  (micropenis,
ilateral  cryptorchidism,  microrquidia,  hypospadias,  clitoral
ypertrophy,  posterior  labial  fusion,  palpable  masses  in  the
abioscrotal  pouches  or  inguinal  region).  In  adolescents  and
dults,  the  most  prevalent  manifestations  were  pubertal
elay,  atypical  pubertal  development,  and  infertility.  These
esults  corroborate  the  literature.4,6--8,11
Despite  this,  the  wide  age  range  in  the  group  with
mbiguous  genitalia,  which  included  teenagers  and  one
dult,  and  the  lack  of  prior  treatment  in  six  patients  in
his  group  drew  attention.  This  result  may  reﬂect  the  under-
iagnosis  and  underreporting  of  GUA,  as  well  as  the  access
ifﬁculty  and  the  disconnection  between  the  health  services
n  the  state.17,18
The  other  clinical  aspects  evaluated----external  and
nternal  genital  morphology  and  presence  or  absence  of
ytogenetic  abnormalities----had  similar  behavior  in  GUD  and
SD  groups.  Consistent  with  the  literature,  the  analysis  of
hese  characteristics  revealed  that,  although  there  was  a
redominance  of  subjects  with  ambiguous  genitalia,  derived
rom  Wolff  and  46,XY  karyotype,  none  of  these  parameters
lone  may  be  considered  for  determination  of  diagnosis  and
reatment.4,6--8,10,11,19--21
The  group  with  genital  ambiguity  is  particularly  illustra-
ive  of  this  situation.  Note  that  in  individuals  with  Prader  1--3
enitalia,  all  types  of  karyotype  were  detected,  whereas  in
he  Prader  4  group  all  had  the  XY  sex  pair  and  in  the  Prader
 group  the  sex  pair  was  XX.  Furthermore,  the  Y  chromo-
ome  was  found  in  patients  with  normal  female  genitalia
ppearance  and  in  patients  with  Müllerian  derivatives,  which
upports  the  need  for  the  use  of  various  resources  in  the
iagnostic  approach  of  GUA.4,6--8,10,11,19--21
The  establishment  of  the  nosological  diagnosis  is  admit-
edly  a  challenge,  especially  in  the  group  with  46,  XY
aryotype,  due  to  extensive  clinical  and  laboratory  over-
ap.  Even  with  the  advent  of  molecular  biology  techniques
o  approach  several  genes  involved  in  sex  differentiation,
he  frequency  of  cases  with  no  diagnosis  ranges  from  33%
o  80%.4,22--24 In  the  present  study,  the  frequency  of  46,XY
ases  without  an  established  nosological  diagnosis  is  in  line
ith  the  literature  data.  The  completion  of  the  sequencing
f  genes  selected  to  reassess  this  result  is  pending.
Groups  of  DGD  and  hypogonadotropic  hypogonadism
roups  have  in  the  karyotype  and  hormone  proﬁle  signiﬁ-
ant  resources  for  diagnosis  deﬁnition.  Among  the  DGD,  the
aryotype  allows  clarify  Turner  syndrome  and  mixed  gonadal
ysgenesis.  Furthermore,  gonadal  biopsy,  indicated  accord-
ng  to  strict  criteria  of  cost-beneﬁt,  is  instructive  in  cases
f  ovariotestis  DSD  and  some  gonadal  dysgenesis.  However,
he  presence  of  renal  abnormalities  and  other  birth  defects
n  patients  with  hypogonadism  should  infer  the  possibility
h
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f  Kallmann  syndrome.6,11 All  this  characteristics  were  seen
his  study.
According  to  expected,  among  all  diagnostic  groups,  the
owest  frequency  of  disagreement  between  genital  morphol-
gy,  karyotype,  and  how  the  child  is  raised  was  seen  in
atients  with  hypogonadism  and  Turner  syndrome,  whereas
he  biggest  disagreements  occurred  in  the  synthesis  defects
r  androgen  action  and  congenital  adrenal  hyperplasia.4,10,25
he  latter,  which  corroborates  the  literature,  was  the  most
requent  nosological  diagnosis.26,27
The  high  frequency  of  consanguinity  and  recurrence  of
he  disorder  in  the  DSD  group  complies  with  the  recognized
ontribution  of  autosomal  recessive  conditions  in  the  etiol-
gy  of  these  disorders.24,26,28 It  is  noteworthy  that  the  State
f  Alagoas  has  high  frequency  of  consanguinity,  which  favors
he  appearance  of  rare  disorders,  as  shown  in  some  cases  of
his  sample.  Maternal  age  ≥35  years  is  an  increased  risk  fac-
or  for  chromosomal  aneuploidies.28 This  correlation  can  be
nferred  in  two  of  the  eight  cases  of  this  sample.
The  biological  complexity  of  sex  differentiation  in
umans  overlaps  the  challenging  psychological,  social,  and
thical  issues  involved  in  these  patients’  management.  Thus,
or  therapeutic  planning,  one  should  take  into  account,
n  addition  to  etiologic  diagnosis,  how  the  child  is  raised,
he  anatomical  conditions  for  external  genital  morphol-
gy  repair,  the  possibility  of  spontaneous  puberty,  and
ertility.4,6--8,10,11 The  deﬁnition  of  the  child’s  social  gender
ole  and  civil  registration  are  particularly  important  and
hould  be  analyzed  comprehensively.  In  the  present  study,
 family  waited  for  clariﬁcation  of  diagnosis  to  deﬁne  how
he  child  would  be  raised  and  the  civil  registration  and  began
ollow-up  with  65  days  of  life,  without  naming  the  child.
The  family  deﬁnition  of  how  a  child  is  raised  regarding
ocial  gender  reveals  the  attributes  of  a  wish.  A  wish  that
nvolves  the  imaginary  representations  that  are  made  of
he  child’s  anatomical  sex  and  the  place  it  occupies  in  the
amily.29 Thus,  the  way  in  which  each  subject  will  apprehend
he  body  itself  and  the  construction  of  psychosexuality  fol-
ows  the  deﬁnition  of  how  the  child  is  raised,  and  not  the
natomical  and  biological  sex.29 In  this  regard,  the  study  of
ne  of  the  sample  cases,30 based  on  the  psychoanalytic  the-
ry,  showed  that  given  a  proper  name  to  a  child  puts  the
hild,  by  virtue  of  that,  in  one  of  the  sexes.
Regarding  civil  registration,  it  is  important  to  note  that
t  does  not  always  follows  the  gender  deﬁnition  by  the
amily,  as  one  of  the  conducts  in  newborns  is  to  guide  par-
nts  to  wait  for  the  diagnostic  conclusion  to  register  the
hild.  At  the  same  time,  the  lack  of  civil  registration  makes
he  access  to  SUS  difﬁcult,  as  it  makes  it  impossible  to
btain  the  documents  required  for  the  national  health  card
hat  provides  access  to  tests  and  procedures.  In  this  study,
pproximately  1/5  of  the  children  came  to  the  clinic  without
 civil  registration;  the  majority  was  cases  of  genital  ambi-
uity  or  malformed  genitalia.  This  result  suggests  that  the
ost  signiﬁcant  factor  in  the  decision  to  register  the  child
s  the  external  genital  morphology  and  indicates  the  need
o  review  the  access  criteria  to  SUS  in  cases  in  which  the
edical  condition  interferes  in  the  civil  registry.
The  frequency  of  follow-up  discontinuation  was  quiteigh  in  this  study,  particularly  in  cases  of  death  and  with-
rawal.  Deaths  occurred  in  patients  with  congenital  adrenal
yperplasia,  related  to  adrenal  crisis,  and  in  babies  born
 clin
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1Proﬁle  of  patients  with  genitourinary  anomalies  treated  in  a
with  multiple  malformations  of  the  GUD  group,  outcomes
consistent  with  the  literature  considering  the  severity  of
conditions.26--28 The  withdrawal  cases  include  patients  who
did  not  return  and  change  of  telephone  numbers  and
addresses.  An  interesting  point  to  note  is  that  the  dis-
tance  between  the  family  home  and  the  follow-up  service
did  not  affect  the  withdrawal.  On  the  other  hand,  simi-
lar  to  what  occurs  with  the  civil  registration,  the  external
genital  morphology  was  a  determining  factor.  The  lower
withdrawal  rates  were  observed  in  patients  with  genital
ambiguity  or  malformation.  These  results  highlight  the  psy-
chosocial  impact  of  external  genital  anatomy  and  indicate
the  need  for  greater  investment  in  welcoming  to  families
and  efforts  to  maintain  the  follow-up  of  patients  with  less
severe  abnormalities  in  view  of  the  implications  of  no  treat-
ment  in  puberty  and  adulthood.
The  overall  results  allowed  us  to  know  the  proﬁle  of
GUA  patients  treated  at  the  SGC/HUPAA/UFAL.  The  gath-
ered  information  provide  subsidies  to  improve  the  clinical
protocols  in  order  to  facilitate  and  streamline  the  manage-
ment  of  cases  and  approaches  decisions  based  on  evidence
and  speciﬁc  health  needs  of  individuals.  Two  important  lim-
itations  of  the  study  are  the  large  number  of  cases  whose
follow-up  was  discontinued  and  cases  still  undiagnosed  that,
in  this  group,  depends  heavily  on  the  investigation  of  genes
not  yet  available  in  the  SUS.  Despite  this,  an  aspect  of
great  importance  was  the  establishment  of  partnerships  with
research  institutions  to  access  to  diagnostic  tests.  Locally,
the  challenge  before  us  is  the  effective  incorporation  of
other  specialties  in  this  proposal,  in  the  perspective  of  a
multidisciplinary  approach  in  tune  with  the  guidelines  and
principles  of  the  Política  Nacional  de  Atenc¸ão Integral  às
Pessoas  com  Doenc¸as Raras.
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